CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study

Overview of attention for article published in Cancer Medicine, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 1,710 followers.

RT @Sarcoma_papers: CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001…

CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study https://t.co/CXBO4Zdxtl

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.